Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01328769 · ClinicalTrials.gov registry record · Phase 4

Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)

A Phase 4 study of Hypertension, sponsored by Paul N. Hopkins.

Completed
Registry status
Phase 4
Development phase
49
Enrollment target
1
Study location

NCT01328769: Completed Phase 4 study of Hypertension, sponsored by Paul N. Hopkins.

NCT01328769 is a Phase 4 study of Hypertension that has completed, run by Paul N. Hopkins. The registered enrollment target is 49 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01328769, a Phase 4 study of Hypertension, has completed, sponsored by Paul N. Hopkins.

COMPLETED
Registry status
Phase 4
Development phase
49 participants
Enrollment target
1
Study location

Study Summary

In this study the investigators will recruit hypertensive subjects with higher than average uric acid levels to test the effect of lowering uric acid with febuxostat on several measures as listed below. This will be a randomized, double-blind, placebo-controlled, parallel group study.

Conditions Studied

Hypertension

Interventions

  • DRUG Placebo
  • DRUG Febuxostat

Study Locations (1)

Utah

  • Cardiovascular Genetics, University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2011-03
Est. Completion 2014-01
Phase Phase 4

Sponsor

Paul N. Hopkins

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01328769

The ClinicalTrials.gov registry entry for NCT01328769 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The listed sponsor is Paul N. Hopkins, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01328769 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT01328769 about?

NCT01328769 is a clinical study titled "Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)". In this study the investigators will recruit hypertensive subjects with higher than average uric acid levels to test the effect of lowering uric acid with febuxostat on several measures as listed below. This will be a randomized, double-blind, placebo-controlled, parallel group study.

What is the current status of trial NCT01328769?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 49 participants. The study started on 2011-03. Estimated completion is 2014-01.

What conditions does trial NCT01328769 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT01328769?

The interventions under investigation include: Placebo (DRUG), Febuxostat (DRUG).

Who is sponsoring clinical trial NCT01328769?

This trial is sponsored by Paul N. Hopkins, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01328769 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypertension

All registered trials for this condition

Utah

All trials with a study site in Utah

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.